The Continental landscape is witnessing a shifting evolution in the view of psychedelics. Recently stigmatized, these substances have begun to be explored for their medical applications. From Switzerland, where clinical trials are in progress, to the Italy, where public discourse is expanding, Europe is at the forefront in this transformation of co